November 2008

Clinilabs Names Greenberg Director of Expanded Unit

Wednesday, November 26, 2008

New York, NY-based contract research organization (CRO) Clinilabs appointed Howard Greenberg, M.D., senior medical director of the company’s newly expanded clinical pharmacology unit. Greenberg has served as the principal investigator or co-investigator for more than 100 clinical trials and co-authored more than 30 peer-reviewed research publications. Most recently, he was group medical director at Bristol-Meyers Squibb.

[Read More]

SFDA, Big Pharma Share Concerns at Shanghai Conference

Monday, November 24, 2008

In his regulatory keynote address at the China Trials 2008 conference in Shanghai, Dr. Yi Feng, director, Office of Review Management, Center for Drug Evaluation (CDE), State Food and Drug Administration (CFDA) gave a broad overview of the evolution of global clinical trials in China and pinpointed future trends and goals in the country.

[Read More]

Rural Population Key to China’s Clinical Research Market

Friday, November 21, 2008

In his presentation at China Trials 2008 in Shanghai, “Conducting Global Post-Marketing Surveillance Studies in China—Opportunity and Practical Issues,” Mark Engel, president and chairman of Excel PharmaStudies, a large China-based contract research organization, identified two megatrends that will drive post-marketing surveillance studies to China: the rapid aging of its population and its increasingly insured rural population.

[Read More]

CenterWatch Wins Gold for Best Healthcare Content

Thursday, November 20, 2008

CenterWatch, a global source for clinical trials information, announced today that it is the three-time recipient of the Gold eHealthcare Leadership Award for Best Health/Healthcare Content in the Other Healthcare Sites category presented by Strategic Health Care Communications. The award, given at the 12th Annual Healthcare Internet Conference in Orlando, Fla., marks the fourth consecutive year CenterWatch has been honored winning platinum in 2005.

[Read More]

Etrials Appoints Permanent CEO

Friday, November 14, 2008

Just a day after releasing disappointing third quarter results, Morrisville, N.C.-based eClinical company etrials named a new president and CEO, M. Denis Connaghan, replacing interim president and CEO Chuck Piccirillo. Piccirillo, who will resume his position as vice president of technology, has served as interim CEO since the resignation of Eugene “Chip” Jennings in July. Connaghan was formerly managing director within Marsh USA’s Global Operations.

[Read More]